Does Rallies show 13F holders for PODD?

Yes. Rallies tracks hedge fund and 13F ownership data for PODD, including fund names, share counts, latest tracked quarter, and position changes when available.

Is PODD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PODD. It does not provide personalized investment advice.

PODD (Insulet Corporation) Stock Analysis - Hedge Fund Holdings

Insulet Corporation (PODD) is a publicly traded Healthcare sector company. As of May 21, 2026, PODD trades at $157.13 with a market cap of $10.56B and a P/E ratio of 36.47. PODD moved +1.29% today. Year to date, PODD is -44.77%; over the trailing twelve months it is -52.18%. Its 52-week range spans $145.59 to $354.88. Analyst consensus is buy with an average price target of $262.52. Rallies surfaces PODD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns PODD stock?

Hedge funds tracked by Rallies that own PODD include D1 Capital, Panagora Asset, Bridgewater Associates, Redmile Group, and Pinebridge Investments. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Insulet Corporation.

PODD Key Metrics

Key financial metrics for PODD
Metric	Value
Price	$157.13
Market Cap	$10.56B
P/E Ratio	36.47
EPS	$4.30
Dividend Yield	0.00%
52-Week High	$354.88
52-Week Low	$145.59
Volume	0
Avg Volume	0
Revenue (TTM)	$2.90B
Net Income	$302.80M
Gross Margin	71.01%

Top Hedge Funds Holding PODD

D1 Capital holds 270.65K shares of PODD, changed -72.86% as of Jun 30, 2024.
Panagora Asset holds 43.43K shares of PODD, changed +6.24% as of Jun 30, 2025.
Bridgewater Associates holds 35.34K shares of PODD, changed -38.38% as of Mar 31, 2026.
Redmile Group holds 27.11K shares of PODD, changed +183.60% as of Mar 31, 2025.
Pinebridge Investments holds 23.07K shares of PODD, changed -6.05% as of Jun 30, 2025.

Latest PODD News

Insulet Slides After Q1 Beat as Omnipod 5 Class I Recall Overhang Persists — May 6, 2026
Insulet Q1 Net Income $91.1M, Adjusted EPS $1.42 Tops Estimates — May 6, 2026
Insulet rises as FDA updates Omnipod 5 Class I recall details ahead of earnings — May 1, 2026
Insulet jumps as traders buy ahead of May 6 earnings after 52-week low — Apr 30, 2026
Insulet drops 4% as FDA recall database highlights Omnipod 5 Pod action — Apr 29, 2026

Recent PODD Insider Trades

MINOGUE MICHAEL R bought 2.03K (~$499.85K) on Feb 25, 2026.
McEvoy Ashley bought 4.30K (~$1.03M) on Feb 20, 2026.
Frederick Wayne A.I. sold 1.85K (~$542.51K) on Dec 15, 2025.

PODD Analyst Consensus

23 analysts cover PODD: 0 strong buy, 18 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $262.52.

Common questions about PODD

Who owns PODD stock?: Hedge funds tracked by Rallies that own PODD include D1 Capital, Panagora Asset, Bridgewater Associates, Redmile Group, and Pinebridge Investments. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Insulet Corporation.
Does Rallies show 13F holders for PODD?: Yes. Rallies tracks hedge fund and 13F ownership data for PODD, including fund names, share counts, latest tracked quarter, and position changes when available.
Is PODD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PODD. It does not provide personalized investment advice.